-
1
-
-
85078370983
-
Effect of Preventan on ScIgA levels in saliva
-
Bártová J, Krátká Z, Benetková K, Krejsa O and Bazata V, 2001. Effect of Preventan on ScIgA levels in saliva. Praktické zubni lékarstvi, 49, 102–106.
-
(2001)
Praktické zubni lékarstvi
, vol.49
, pp. 102-106
-
-
Bártová, J.1
Krátká, Z.2
Benetková, K.3
Krejsa, O.4
Bazata, V.5
-
2
-
-
0042029628
-
Antibacterial effects of the milk protein lactoferrin
-
May-June issue
-
Berkhout B, Floris R, Recio I and Visser S, 2003a. Antibacterial effects of the milk protein lactoferrin. AGRO Food Industry hi-tech, May-June issue, 32–23.
-
(2003)
AGRO Food Industry hi-tech
, pp. 32-23
-
-
Berkhout, B.1
Floris, R.2
Recio, I.3
Visser, S.4
-
3
-
-
0037843234
-
Antiviral effects of the milk protein lactoferrin
-
March-April issue
-
Berkhout B, Floris R, Recio I and Visser S, 2003b. Antiviral effects of the milk protein lactoferrin. AGRO Food Industry hi-tech, March-April issue, 43–46.
-
(2003)
AGRO Food Industry hi-tech
, pp. 43-46
-
-
Berkhout, B.1
Floris, R.2
Recio, I.3
Visser, S.4
-
4
-
-
79952100586
-
Mucosal immunity and illness incidence in elite rugby union players across a season
-
Cunniffe B, Griffiths H, Proctor W, Davies B, Baker JS and Jones KP, 2011. Mucosal immunity and illness incidence in elite rugby union players across a season. Medicine & Science in Sports & Exercise, 43, 388–397.
-
(2011)
Medicine & Science in Sports & Exercise
, vol.43
, pp. 388-397
-
-
Cunniffe, B.1
Griffiths, H.2
Proctor, W.3
Davies, B.4
Baker, J.S.5
Jones, K.P.6
-
5
-
-
33748416650
-
Interactions of lactoferrin with cells involved in the immune system
-
Legrand D, Elass E, Carpentier M and Mazurier J, 2006. Interactions of lactoferrin with cells involved in the immune system. Biochemistry and Cell Biology, 84, 282–290.
-
(2006)
Biochemistry and Cell Biology
, vol.84
, pp. 282-290
-
-
Legrand, D.1
Elass, E.2
Carpentier, M.3
Mazurier, J.4
-
6
-
-
61749101507
-
Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes
-
Neville V, Gleeson M and Folland JP, 2008. Salivary IgA as a risk factor for upper respiratory infections in elite professional athletes. Medicine & Science in Sports & Exercise, 40, 1228–1236.
-
(2008)
Medicine & Science in Sports & Exercise
, vol.40
, pp. 1228-1236
-
-
Neville, V.1
Gleeson, M.2
Folland, J.P.3
-
7
-
-
85078368615
-
Effect of Preventan® Akut on Secretory antibodies IgA levels in Saliva of healthy individuals
-
Podzimek S, Svobodová K, Mrklas L, Procházková J, Bártová J, Tomásová E and Hromádka R, 2007. Effect of Preventan® Akut on Secretory antibodies IgA levels in Saliva of healthy individuals. Practicus, 6, 24–25.
-
(2007)
Practicus
, vol.6
, pp. 24-25
-
-
Podzimek, S.1
Svobodová, K.2
Mrklas, L.3
Procházková, J.4
Bártová, J.5
Tomásová, E.6
Hromádka, R.7
-
8
-
-
85078394736
-
-
unpublished., Study report, undated
-
Průcha M, Zácek P, Táborsky L and Dostál M, unpublished. Using Preventan® in children after infective mononucleosis. Study report, undated.
-
Using Preventan® in children after infective mononucleosis
-
-
Průcha, M.1
Zácek, P.2
Táborsky, L.3
Dostál, M.4
-
9
-
-
85078381585
-
-
unpublished, (a)., Study report, undated
-
Richter J, Jilek D, Král V, Vorderwinkler A, Kolinová T and Hamousová M, unpublished, (a). Preliminary findings in senior population depending on Juwim (now ProteQuine®) supplementation. Study report, undated.
-
Preliminary findings in senior population depending on Juwim (now ProteQuine®) supplementation
-
-
Richter, J.1
Jilek, D.2
Král, V.3
Vorderwinkler, A.4
Kolinová, T.5
Hamousová, M.6
-
10
-
-
85078377000
-
-
unpublished, (b)., Study report, undated
-
Richter J, Richterová S and Kolinová T, unpublished, (b). Findings in Preventan® supplemented child group. Study report, undated.
-
Findings in Preventan® supplemented child group
-
-
Richter, J.1
Richterová, S.2
Kolinová, T.3
-
12
-
-
0343288991
-
Lactoferrin regulates the immune response in post-surgical patients
-
Zimecki M, Wlaszczyk A, Wojciechowski R, Dawiskiba J and Kruzel M, 2001. Lactoferrin regulates the immune response in post-surgical patients. Archivum Immunologiae et Therapiae Experimentalis, 49, 325–333.
-
(2001)
Archivum Immunologiae et Therapiae Experimentalis
, vol.49
, pp. 325-333
-
-
Zimecki, M.1
Wlaszczyk, A.2
Wojciechowski, R.3
Dawiskiba, J.4
Kruzel, M.5
|